Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1995 Aug;40(2):161–165. doi: 10.1111/j.1365-2125.1995.tb05771.x

Lack of interaction between nefazodone and cimetidine: a steady state pharmacokinetic study in humans.

R H Barbhaiya 1, U A Shukla 1, D S Greene 1
PMCID: PMC1365177  PMID: 8562300

Abstract

The steady-state pharmacokinetic interaction between nefazodone and cimetidine was evaluated in a three-period crossover study consisting of three treatments of 1 week duration with a 1 week washout between treatments. The 18 healthy, male study subjects received: nefazodone hydrochloride 200 mg twice daily (every 12 h) for 6 days; cimetidine 300 mg four times daily for 6 days; and 200 mg nefazodone hydrochloride twice daily + 300 mg cimetidine four times daily for 6 days. On day 7 of each treatment, only the morning dose was administered. Serial blood samples were collected for pharmacokinetic analysis after drug administration on day 7 of each treatment; blood samples for trough levels (Cmin) to assess attainment of steady state, were also collected just prior to the morning doses on days 2-7 of each study period. Plasma samples were assayed for cimetidine, and nefazodone and its metabolites hydroxynefazodone and m-chlorophenylpiperazine by specific, validated h.p.l.c. methods. Statistical analyses of Cmin data indicated that, regardless of treatment, steady state was achieved for cimetidine by day 2 and for nefazodone and its metabolites by day 3 of multiple dosing, and that there were no significant differences in Cmin levels between treatments. When nefazodone and cimetidine were co-administered for 1 week, no change in steady-state pharmacokinetic parameters for cimetidine, nefazodone or hydroxynefazodone was observed compared with each drug dosed alone.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
161

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abernethy D. R., Greenblatt D. J., Divoll M., Moschitto L. J., Harmatz J. S., Shader R. I. Interaction of cimetidine with the triazolobenzodiazepines alprazolam and triazolam. Psychopharmacology (Berl) 1983;80(3):275–278. doi: 10.1007/BF00436169. [DOI] [PubMed] [Google Scholar]
  2. Feighner J. P., Pambakian R., Fowler R. C., Boyer W. F., D'Amico M. F. A comparison of nefazodone, imipramine, and placebo in patients with moderate to severe depression. Psychopharmacol Bull. 1989;25(2):219–221. [PubMed] [Google Scholar]
  3. Franc J. E., Duncan G. F., Farmen R. H., Pittman K. A. High-performance liquid chromatographic method for the determination of nefazodone and its metabolites in human plasma using laboratory robotics. J Chromatogr. 1991 Sep 18;570(1):129–138. doi: 10.1016/0378-4347(91)80207-s. [DOI] [PubMed] [Google Scholar]
  4. Hetzel D. J., Bochner F., Hallpike J. F., Shearman D. J., Hann C. S. Cimetidine interaction with phenytoin. Br Med J (Clin Res Ed) 1981 May 9;282(6275):1512–1512. doi: 10.1136/bmj.282.6275.1512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Khan A., Langley S. J., Mullins F. G., Dixon J. S., Toon S. The pharmacokinetics and pharmacodynamics of nifedipine at steady state during concomitant administration of cimetidine or high dose ranitidine. Br J Clin Pharmacol. 1991 Oct;32(4):519–522. doi: 10.1111/j.1365-2125.1991.tb03943.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Klotz U., Reimann I. Delayed clearance of diazepam due to cimetidine. N Engl J Med. 1980 May 1;302(18):1012–1014. doi: 10.1056/NEJM198005013021807. [DOI] [PubMed] [Google Scholar]
  7. Knodell R. G., Browne D. G., Gwozdz G. P., Brian W. R., Guengerich F. P. Differential inhibition of individual human liver cytochromes P-450 by cimetidine. Gastroenterology. 1991 Dec;101(6):1680–1691. doi: 10.1016/0016-5085(91)90408-d. [DOI] [PubMed] [Google Scholar]
  8. Kunitani M. G., Johnson D. A., Upton R. A., Riegelman S. Convenient and sensitive high-performance liquid chromatography assay for cimetidine in plasma or urine. J Chromatogr. 1981 Jun 12;224(1):156–161. doi: 10.1016/s0378-4347(00)80151-6. [DOI] [PubMed] [Google Scholar]
  9. Lorenzo B., Drayer D. E. Improved method for the measurement of cimetidine in human serum by reverse-phase high-pressure liquid chromatography. J Lab Clin Med. 1981 Apr;97(4):545–550. [PubMed] [Google Scholar]
  10. Mayol R. F., Cole C. A., Luke G. M., Colson K. L., Kerns E. H. Characterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma. Drug Metab Dispos. 1994 Mar-Apr;22(2):304–311. [PubMed] [Google Scholar]
  11. Pourbaix S., Desager J. P., Hulhoven R., Smith R. B., Harvengt C. Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects. Int J Clin Pharmacol Ther Toxicol. 1985 Aug;23(8):447–451. [PubMed] [Google Scholar]
  12. Silver B. A., Bell W. R. Cimetidine potentiation of the hypoprothrombinemic effect of warfarin. Ann Intern Med. 1979 Mar;90(3):348–349. doi: 10.7326/0003-4819-90-3-348. [DOI] [PubMed] [Google Scholar]
  13. Somogyi A., Muirhead M. Pharmacokinetic interactions of cimetidine 1987. Clin Pharmacokinet. 1987 May;12(5):321–366. doi: 10.2165/00003088-198712050-00002. [DOI] [PubMed] [Google Scholar]
  14. Upton R. A. Pharmacokinetic interactions between theophylline and other medication (Part I). Clin Pharmacokinet. 1991 Jan;20(1):66–80. doi: 10.2165/00003088-199120010-00005. [DOI] [PubMed] [Google Scholar]
  15. Wilkinson C. F., Hetnarski K., Yellin T. O. Imidazole derivatives--a new class of microsomal enzyme inhibitors. Biochem Pharmacol. 1972 Dec 1;21(23):3187–3192. doi: 10.1016/0006-2952(72)90147-5. [DOI] [PubMed] [Google Scholar]
  16. Wood M. Pharmacokinetic drug interactions in anaesthetic practice. Clin Pharmacokinet. 1991 Oct;21(4):285–307. doi: 10.2165/00003088-199121040-00005. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES